Preparation of Platelet Concentrates

Methods in Molecular Biology

Volumn 728, Issue , 2011, Pages 267-278

  Greening, David W ^b   Sparrow, Rosemary L ^a   Simpson, Richard J ^b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b NONE

Author keywords

Apheresis; Buffy coat; Platelet concentrate; Platelet rich plasma; Proteomics; Protocol; Research; SOP; Transfusion

Indexed keywords

ARTICLE; BLOOD BUFFY COAT; BLOOD SAMPLING; CHEMISTRY; HUMAN; METHODOLOGY; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

BLOOD BUFFY COAT; BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; HUMANS; PLATELET-RICH PLASMA;

EID: 79960128383     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-068-3_18     Document Type: Chapter

References (55)

1. Harrison, P. and A.H. Goodall (2008), “Message in the platelet”--more than just vestigial mRNA! Platelets. 19(6), 395–404.
2. Garcia, A. (2006), Proteome analysis of signaling cascades in human platelets. Blood Cells Mol Dis. 36(2), 152–156.
3. Gnatenko, D.V., P.L. Perrotta, and W.F. Bahou (2006), Proteomic approaches to dissect platelet function: one-half of the story. Blood. 108(13), 3983–91.
4. Senzel, L., D.V. Gnatenko, and W.F. Bahou (2009), The platelet proteome. Curr Opin Hematol. 16(5), 329–33.
5. Greening, D.W., K. Glenister, R. Sparrow, et al., Enrichment of human platelet
6. Jurk, K. and B.E. Kehrel (2005), Platelets: physiology and biochemistry. Semin Thromb Hemost. 31(4), 381–92.
7. George, J.N. (2000), Platelets. Lancet. 355(9214), 1531–9.
8. Harrison, P. (2005), Platelet function analysis. Blood Rev. 19(2), 111–23.
9. Italiano, J.E., Jr. and R.A. Shivdasani (2003), Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost. 1(6), 1174–82.
10. McRedmond, J.P., S.D. Park, D.F. Reilly, et al. (2004), Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics. 3(2), 133–44. requires complementary proteomic approaches. Transfusion. 48(3), 425–35.
11. Sacristan, D., M. Marques, S. Spinella, et al. (2008), Modifications by Olmesartan medox-omil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin. Appl. 2(9), 1300–1312.
12. Springer, D.L., J.H. Miller, S.L. Spinelli, et al. (2009), Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res. 8(5), 2261–72.
13. van Rhenen, D.J., J. Vermeij, J. de Voogt, et al. (1998), Quality and standardization in blood component preparation with an automated blood processing technique. Transfus Med. 8(4), 319–24.
14. Murphy, S. (2005), Platelets from pooled buffy coats: an update. Transfusion. 45(4), 634–9.
15. Murphy, S. and F.H. Gardner (1969), Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage. N Engl J Med. 280(20), 1094–8.
16. Wandall, H.H., K.M. Hoffmeister, A.L. Sorensen, et al. (2008), Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets. Blood. 111(6), 3249–56.
17. Neufeld, M., U. Nowak-Gottl, and R. Junker (1999), Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation. Clin Chem. 45(11), 2030–3.
18. Gulliksson, H. (2007), Platelet additive solutions: current status. Immunohematology. 23(1), 14–9.
19. van der Meer, P.F. (2007), Platelet additive solutions: a future perspective. Transfus Clin Biol. 14(6), 522–5.
20. Vassallo, R.R. and S. Murphy (2006), A critical comparison of platelet preparation methods. Curr Opin Hematol. 13(5), 323–30.
21. Greening, D.W., K.M. Glenister, R.L. Sparrow, et al. (2010), International blood collection and storage: Clinical use of blood products. J Proteomics. 73(3), 386–395.
22. Murphy, S. and F.H. Gardner (1975), Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability. Blood. 46(2), 209–18.
23. Holme, S., K. Vaidja, and S. Murphy (1978), Platelet storage at 22 degrees C: effect of type of agitation on morphology, viability, and function in vitro. Blood. 52(2), 425–35.
24. Snyder, E.L., M. Ezekowitz, R. Aster, et al. (1985), Extended storage of platelets in a new membrane-cytoskeletal proteins for proteomic analysis, in Proteomic analysis of membrane proteins: Methods and protocols. Methods in Molecular Medicine Series., M. Pierce, Editor. 2009, Humana Press. Vol. 528, 245–258.
25. Greening, D.W., K.M. Glenister, E.A. Kapp, et al. (2008), Comparison of human platelet-membrane cytoskeletal proteins with the plasma proteome: Towards understanding the platelet-plasma nexus. Proteomics Clin. Appl. 2, 63–77.
26. Moebius, J., R.P. Zahedi, U.U. Lewandrowski, et al. (2005), The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics. 4(11), 1754–61.
27. Qureshi, A.H., V. Chaoji, D. Maiguel, et al. (2009), Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One. 4(10), e7627.
28. Dittrich, M., I. Birschmann, S. Mietner, et al. (2008), Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol. 28(7), 1326–31.
29. Zahedi, R.P., U. Lewandrowski, J. Wiesner, et al. (2008), Phosphoproteome of resting human platelets. J Proteome Res. 7(2), 526–34.
30. Gevaert, K., M. Goethals, L. Martens, et al. (2003), Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 21(5), 566–9.
31. Garcia, B.A., D.M. Smalley, H. Cho, et al. (2005), The platelet microparticle proteome. J Proteome Res. 4(5), 1516–1521.
32. Jin, M., G. Drwal, T. Bourgeois, et al. (2005), Distinct proteome features of plasma microparticles. Proteomics. 5(7), 1940–52.
33. Janowska-Wieczorek, A., M. Wysoczynski, J. Kijowski, et al. (2005), Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 113(5), 752–60.
34. Thiele, T., L. Steil, S. Gebhard, et al. (2007), Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion. 47(7), 1221–33.
35. Glenister, K.M., K.A. Payne, and R.L. Sparrow (2008), Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion. 48(1), 99–107.
36. Thon, J.N., P. Schubert, M. Duguay, et al. (2008), Comprehensive proteomic analysis of protein changes during platelet storage storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion. 49(11), 2311–8.
37. Van der Meer, P.F., J.L. Kerkhoffs, J. Curvers, et al. (2009), In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang. 98, 517–24.
38. Moroff, G. and N.L. Luban (1997), The irradiation of blood and blood components to prevent graft-versus-host disease: technical issues and guidelines. Transfus Med Rev. 11(1), 15–26.
39. Kelley, W.E., B.B. Edelman, C.B. Drachenberg, et al. (2009), Washing platelets in neutral, calcium-free, Ringer’s acetate. Transfusion. 49(9), 1917–23.
40. Balint, B., D. Paunovic, D. Vucetic, et al. (2006), Controlled-rate versus uncontrolled-rate freezing as predictors for platelet cryopreservation efficacy. Transfusion. 46(2), 230–5.
41. Hornsey, V.S., L. McMillan, A. Morrison, et al. (2008), Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion. 48(12), 2508–14.
42. Cardigan, R., C. Turner, and P. Harrison (2005), Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang. 88(3), 153–63.
43. Albanyan, A.M., P. Harrison, and M.F. Murphy (2009), Markers of platelet activation and apoptosis during storage of apheresis-and buffy coat-derived platelet concentrates for 7 days. Transfusion. 49(1), 108–17.
44. Tynngard, N. (2009), Preparation, storage and quality control of platelet concentrates. Transfus Apher Sci. 41(2), 97–104. plastic container. II. In vivo response to infusion of platelets stored for 5 days. Transfusion. 25(3), 209–14.
45. AuBuchon, J.P., H. Taylor, S. Holme, et al. (2005), In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion. 45(8), 1356–61.
46. Cardigan, R., J. Sutherland, M. Garwood, et al. (2008), In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang. 94(2), 103–12.
47. Skripchenko, A., A. Myrup, D. Thompson-Montgomery, et al. (2010), Periods without agitation diminish platelet mitochondrial function during storage. Transfusion. 50(2), 390–9.
48. Mathai, J. (2009), Problem of bacterial contamination in platelet concentrates. Transfus Apher Sci. 41(2), 139–44.
49. Shrivastava, M. (2009), The platelet storage lesion. Transfus Apher Sci. 41(2), 105–13.
50. Dzik, S. (1993), Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. Transfus Med Rev. 7(2), 65–77.
51. Blajchman, M.A. (2006), The clinical benefits of the leukoreduction of blood products. J Trauma. 60(6 Suppl), S83–90.
52. Dodd, R., W. Kurt Roth, P. Ashford, et al. (2009), Transfusion medicine and safety. Biologicals. 37(2), 62–70.
53. Allain, J.P., S.L. Stramer, A.B. Carneiro-Proietti, et al. (2009), Transfusion-transmitted infectious diseases. Biologicals. 37(2), 71–7.
54. Solheim, B.G. (2008), Pathogen reduction of blood components. Transfus Apher Sci. 39(1), 75–82.
55. Picker, S.M., V. Schneider, L. Oustianskaia, et al. (2009), Cell viability during platelet